Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Mar;79(3):692–697. doi: 10.1172/JCI112872

Effect of methotrexate on intracellular folate pools in purified myeloid precursor cells from normal human bone marrow.

J Baram, C J Allegra, R L Fine, B A Chabner
PMCID: PMC424178  PMID: 3818945

Abstract

We investigated the effects of the antifolate methotrexate on intracellular folate pools of human myeloid precursor cells (MPCs). Immature MPCs, representing 3.2% of the original marrow population, were selected from normal human bone marrow by immune rosetting. The intracellular folate pools were labeled by incubation with 5 X 10(-8) M [3H]5-formyl-FH4 and were quantitated by high performance liquid chromatography. The predominant folates were 5-methyl-tetrahydrofolate (5-methyl-FH4) (36%), 10-formyl-FH4 (41.4%), 5-formyl-FH4 (12.3%), and FH4 (10.3%). A 12-h exposure to 1 microM methotrexate (MTX) resulted in a 34% reduction in the intracellular concentration of 10-formyl-FH4, a 61% decrease in 5-formyl-FH4, and a 62% decrease in 5-methyl-FH4, as well as the appearance and progressive expansion of the FH2 and 10-formyl-FH2 pools. These changes were maximal after 4 h of incubation with MTX. Paralleling the changes in folates, particularly the increase in FH2, were a 64% reduction in myeloid colony formation and a 77% depression of de novo purine synthesis after 4 h of MTX. We conclude that MTX does not produce quantitative depletion of 10-formyl-FH4 and that its antipurine effect may be mediated by direct inhibition of de novo purine synthesis by FH2 and, at later time points, by MTX polyglutamates.

Full text

PDF
692

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allegra C. J., Chabner B. A., Drake J. C., Lutz R., Rodbard D., Jolivet J. Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates. J Biol Chem. 1985 Aug 15;260(17):9720–9726. [PubMed] [Google Scholar]
  2. Allegra C. J., Drake J. C., Jolivet J., Chabner B. A. Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates. Proc Natl Acad Sci U S A. 1985 Aug;82(15):4881–4885. doi: 10.1073/pnas.82.15.4881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Allegra C. J., Fine R. L., Drake J. C., Chabner B. A. The effect of methotrexate on intracellular folate pools in human MCF-7 breast cancer cells. Evidence for direct inhibition of purine synthesis. J Biol Chem. 1986 May 15;261(14):6478–6485. [PubMed] [Google Scholar]
  4. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  5. COX E. V., MATTHEWS D. M., MEYNELL M. J., COOKE W. T., GADDIE R. Cyanocobalamin, ascorbic acid and pteroylglutamates in normal and megaloblastic bone marrow. Blood. 1960 Mar;15:376–387. [PubMed] [Google Scholar]
  6. Curt G. A., Jolivet J., Bailey B. D., Carney D. N., Chabner B. A. Synthesis and retention of methotrexate polyglutamates by human small cell lung cancer. Biochem Pharmacol. 1984 May 15;33(10):1682–1685. doi: 10.1016/0006-2952(84)90292-2. [DOI] [PubMed] [Google Scholar]
  7. Dolnick B. J., Cheng Y. C. Human thymidylate synthetase. II. Derivatives of pteroylmono- and -polyglutamates as substrates and inhibitors. J Biol Chem. 1978 May 25;253(10):3563–3567. [PubMed] [Google Scholar]
  8. Duch D. S., Bowers S. W., Nichol C. A. Analysis of folate cofactor levels in tissues using high-performance liquid chromatography. Anal Biochem. 1983 Apr 15;130(2):385–392. doi: 10.1016/0003-2697(83)90604-8. [DOI] [PubMed] [Google Scholar]
  9. Fabre I., Fabre G., Goldman I. D. Polyglutamylation, an important element in methotrexate cytotoxicity and selectivity in tumor versus murine granulocytic progenitor cells in vitro. Cancer Res. 1984 Aug;44(8):3190–3195. [PubMed] [Google Scholar]
  10. Fry D. W., Anderson L. A., Borst M., Goldman I. D. Analysis of the role of membrane transport and polyglutamation of methotrexate in gut and the Ehrlich tumor in vivo as factors in drug sensitivity and selectivity. Cancer Res. 1983 Mar;43(3):1087–1092. [PubMed] [Google Scholar]
  11. Golde D. W., Quan S. G., Cline M. J. Human T lymphocyte cell line producing colony-stimulating activity. Blood. 1978 Nov;52(5):1068–1072. [PubMed] [Google Scholar]
  12. Goldman I. D. A model system for the study of heteroexchange diffusion: methotrexate-folate interactions in L1210 leukemia and Ehrlich ascites tumor cells. Biochim Biophys Acta. 1971 Jun 1;233(3):624–634. doi: 10.1016/0005-2736(71)90162-3. [DOI] [PubMed] [Google Scholar]
  13. Goldman I. D., Lichtenstein N. S., Oliverio V. T. Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell. J Biol Chem. 1968 Oct 10;243(19):5007–5017. [PubMed] [Google Scholar]
  14. Griffin J. D., Beveridge R. P., Schlossman S. F. Isolation of myeloid progenitor cells from peripheral blood of chronic myelogenous leukemia patients. Blood. 1982 Jul;60(1):30–37. [PubMed] [Google Scholar]
  15. Griffin J. D., Ritz J., Nadler L. M., Schlossman S. F. Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest. 1981 Oct;68(4):932–941. doi: 10.1172/JCI110348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hoffbrand A. V., Newcombe B. F. Leucocyte folate in vitamin B 12 and folate deficiency and in leukaemia. Br J Haematol. 1967 Nov;13(6):954–966. doi: 10.1111/j.1365-2141.1967.tb08866.x. [DOI] [PubMed] [Google Scholar]
  17. Jolivet J., Chabner B. A. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase. J Clin Invest. 1983 Sep;72(3):773–778. doi: 10.1172/JCI111048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jolivet J., Schilsky R. L., Bailey B. D., Drake J. C., Chabner B. A. Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cells. J Clin Invest. 1982 Aug;70(2):351–360. doi: 10.1172/JCI110624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jolivet J., Schilsky R. L. High-pressure liquid chromatography analysis of methotrexate polyglutamates in cultured human breast cancer cells. Biochem Pharmacol. 1981 Jun 1;30(11):1387–1390. doi: 10.1016/0006-2952(81)90330-0. [DOI] [PubMed] [Google Scholar]
  20. Koizumi S., Curt G. A., Fine R. L., Griffin J. D., Chabner B. A. Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow. J Clin Invest. 1985 Mar;75(3):1008–1014. doi: 10.1172/JCI111761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Koizumi S., Fine R. L., Curt G. A., Griffin J. D., Chabner B. A. Enrichment of myeloid progenitor cells from normal human bone marrow using an immune-rosette technique. Exp Hematol. 1985 Jul;13(6):560–565. [PubMed] [Google Scholar]
  22. Lavoie A., Tripp E., Parsa K., Hoffbrand A. V. Polyglutamate forms of folate in resting and proliferating mammalian tissues. Clin Sci Mol Med. 1975 Jan;48(1):67–73. doi: 10.1042/cs0480067. [DOI] [PubMed] [Google Scholar]
  23. McMartin K. E., Virayotha V., Tephly T. R. High-pressure liquid chromatography separation and determination of rat liver folates. Arch Biochem Biophys. 1981 Jun;209(1):127–136. doi: 10.1016/0003-9861(81)90264-2. [DOI] [PubMed] [Google Scholar]
  24. Moran R. G., Colman P. D. A simple procedure for the synthesis of high specific activity tritiated (6S)-5-formyltetrahydrofolate. Anal Biochem. 1982 May 1;122(1):70–78. doi: 10.1016/0003-2697(82)90252-4. [DOI] [PubMed] [Google Scholar]
  25. Pheasant A. E., Bates J., Blair J. A., Nayyir-Mazhir R. Investigations of tissue folates in normal and malignant tissues. Br J Cancer. 1983 Mar;47(3):393–398. doi: 10.1038/bjc.1983.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Pike B. L., Robinson W. A. Human bone marrow colony growth in agar-gel. J Cell Physiol. 1970 Aug;76(1):77–84. doi: 10.1002/jcp.1040760111. [DOI] [PubMed] [Google Scholar]
  27. Poser R. G., Sirotnak F. M., Chello P. L. Differential synthesis of methotrexate polyglutamates in normal proliferative and neoplastic mouse tissues in vivo. Cancer Res. 1981 Nov;41(11 Pt 1):4441–4446. [PubMed] [Google Scholar]
  28. SWENDSEID M. E., BETHELL F. H., BIRD O. D. The concentration of folic acid in leukocytes; observations on normal subjects and persons with leukemia. Cancer Res. 1951 Nov;11(11):864–867. [PubMed] [Google Scholar]
  29. Saxon A., Stevens R. H., Golde D. W. T-lymphocyte variant of hairy-cell leukemia. Ann Intern Med. 1978 Mar;88(3):323–326. doi: 10.7326/0003-4819-88-3-323. [DOI] [PubMed] [Google Scholar]
  30. Scott J. M. The identification of the intracellular folate coenzymes of different cell types. Biochem Soc Trans. 1976;4(5):845–850. doi: 10.1042/bst0040845. [DOI] [PubMed] [Google Scholar]
  31. Trubowitz S., Frank O., Baker H. Survey of vitamin B12 and folate in the serum and marrow tissue of hospitalized patients. Am J Clin Nutr. 1974 Jun;27(6):580–583. doi: 10.1093/ajcn/27.6.580. [DOI] [PubMed] [Google Scholar]
  32. Yin M. B., Zakrzewski S. F., Hakala M. T. Relationship of cellular folate cofactor pools to the activity of 5-fluorouracil. Mol Pharmacol. 1983 Jan;23(1):190–197. [PubMed] [Google Scholar]
  33. Yokochi T., Brice M., Rabinovitch P. S., Papayannopoulou T., Stamatoyannopoulos G. Monoclonal antibodies detecting antigenic determinants with restricted expression on erythroid cells: from the erythroid committed progenitor level to the mature erythroblast. Blood. 1984 Jun;63(6):1376–1384. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES